INSIGHTS ON CLINICAL TRIAL DESIGN
-
![It works great until protocol changes]( "It Works Great Until Your Protocol Changes")
It Works Great Until Your Protocol ChangesThe CEO of Korio discusses the challenges of change and how Korio's platform addresses every shifting protocols.
-
![GettyImages-1457639530 inflation report]( "The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting")
The Impact Of High Inflation And The Great Resignation On Clinical Site BudgetingThe twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.
-
![Protocol Flexibility Is A Quality Strategy]( "Protocol Flexibility Is A Quality Strategy")
Protocol Flexibility Is A Quality StrategyAnna-Zeralda Canals Hamann shares how flexible IRT design can help sponsors prepare for changes in supply strategy, dosing, and patient cohorts. Effective RTSM systems are designed to manage uncertainty without disrupting trial operations.
-
![GettyImages-1338924777-digital-patient-enroll-recruit]( "Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads")
Sol-Gel Builds Awareness Of Rare Skin Condition, Generates LeadsExplore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.
-
Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy3/17/2026
Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.
-
What If Therapeutic Area Expertise Isn't The Competitive Advantage We Think It Is?8/13/2026
Rethink vendor evaluation by looking beyond indication experience to discover how cross-trial adaptability, proactive risk management, and team judgment drive true clinical trial resilience.
-
ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials9/18/2025
The ICH E6(R3) updated guidelines present 10 critical changes to make clinical trials more efficient, adaptable, and patient-centric, while upholding the standards of scientific and ethical integrity.
-
RTSM Misalignment Hiding In Your Clinical Trial Protocol5/13/2026
Unclear protocol details can quickly create problems across a clinical trial, but bringing in experienced systems thinkers early to identify gaps before they create downstream issues can help.
-
Making Early Decisions In Psychiatric Drug Development7/30/2026
Quantitative PD measures provide objective evidence of target engagement, support dose selection, strengthen early go/no-go decisions, and help reduce development risk in psychiatric
CLINICAL TRIAL DESIGN SOLUTIONS
-
![patient talking to doctor-GettyImages-1667822839]( "Patient Liaison: Per-Visit Participant Support")
Dedicated Patient Liaison support helps coordinate participant travel, reimbursements, and visit logistics so sites stay focused and study requests keep moving forward.
-
![GettyImages-1219551222-Patient-Person-Recruitment-Select]( "Accelerate Enrollment And Reduce Site Burden")
Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.
-
![GettyImages-1135573728-digital-patient-tablet-recruitment]( "Enhance Clinical Trial Screening And Improve Patient Matching Accuracy")
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
![logistics-discovery-transport-travel-GettyImages-1287428874]( "Safe-To-Site: Confidence In Clinical Trial Travel")
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
![GettyImages-1358151834 ROI]( "Driving Efficiency And ROI In Clinical Trials")
Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.
